KR102027827B1 - Composition comprising lemon balm extract for lipolysis - Google Patents
Composition comprising lemon balm extract for lipolysis Download PDFInfo
- Publication number
- KR102027827B1 KR102027827B1 KR1020190050030A KR20190050030A KR102027827B1 KR 102027827 B1 KR102027827 B1 KR 102027827B1 KR 1020190050030 A KR1020190050030 A KR 1020190050030A KR 20190050030 A KR20190050030 A KR 20190050030A KR 102027827 B1 KR102027827 B1 KR 102027827B1
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- weight
- lipolysis
- composition
- lemon balm
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/606—Nucleosides; Nucleotides; Nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/06—Preparations for care of the skin for countering cellulitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/82—Preparation or application process involves sonication or ultrasonication
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/83—Electrophoresis; Electrodes; Electrolytic phenomena
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/87—Application Devices; Containers; Packaging
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
본 발명은 레몬밤 추출물을 유효성분으로 포함하는 지방 분해용 화장료 조성물에 관한 것이다.The present invention relates to a cosmetic composition for lipolysis comprising lemon balm extract as an active ingredient.
코스메슈티컬(Cosmeceutical)이란 화장품(cosmetics)과 제약(pharmaceuticals)의 합성어로, 약용화장품을 의미한다. 검증된 효능의 의약 성분을 화장품에 접목한 제품이다. 의사, 약사 등 의료 전문가가 연구 개발에 참여한 화장품도 코스메슈티컬에 속한다. 기존 화장품이 피부 관리를 위한 것이라면 코스메슈티컬 제품은 피부 치료에 초점이 맞춰져 있다. Cosmeceutical is a compound word of cosmetics and pharmaceuticals and means medicinal cosmetics. The product combines proven ingredients with cosmetics. Cosmetics in which medical experts such as doctors and pharmacists participated in research and development belong to cosmeceuticals. If existing cosmetics are for skin care, cosmeceutical products are focused on skin treatment.
한편, 비만으로 인한 각종 질병의 증가와 함께, 개인의 미용에 대한 관심이 크게 높아짐에 따라, 다이어트의 하나로 피하 지방을 제거하는 방안이 여러 가지로 강구되고 있다.On the other hand, with the increase of various diseases due to obesity, the interest in personal beauty is greatly increased, various ways to remove the subcutaneous fat as one of the diet.
과도한 피하 지방의 제거 및 피부 탄력의 증진에 효과적인 슬리밍(slimming) 및 안티 셀룰라이트(anti-cellulite) 화장품에 대한 요구도 꾸준히 높아지고 있다. The demand for slimming and anti-cellulite cosmetics that is effective in removing excess subcutaneous fat and promoting skin elasticity is steadily increasing.
이러한 건강 및 미적 관점에서의 비만을 개선하기 위한 방법도 다각적인 측면에서 시도되고 있는데, 종래에 알려져 있는 비만 해소의 방법은 에너지의 섭취를 저해하거나, 에너지 소비를 증대 시킬 목적으로 식이요법, 운동요법, 수술요법, 약물요법 등의 다양한 방법들이 현재 비만의 치료를 위해 사용되고 있다. 그러나, 이러한 방법들이 비만을 완전하게 해결할 수는 없을 뿐만 아니라 요요 현상이나 심각한 부작용들이 보고되고 있어 아직은 안전성에 대한 명확한 보장이 없는 실정이다. 또한, 미적인 관점에서의 비만 해소에는 지방 분해와 더불어 피부에 대한 효능이 부가적으로 요구되므로 상기 요법들의 적용이 모든 필요충분 조건을 충족하기에는 아직 미비한 부분이 많다고 할 수 있다. 따라서, 종래의 물질과 동등하거나 그 이상의 효능을 나타내면서도 인체에 대해서는 좀더 안전한 새로운 물질을 개발해야 할 필요성이 대두되고 있다.In order to improve obesity from a health and aesthetic point of view, various attempts have been made. The conventional methods of resolving obesity are known as diet and exercise therapy for the purpose of inhibiting energy intake or increasing energy consumption. Various methods such as surgery, surgery, and drug therapy are currently used for the treatment of obesity. However, not only do these methods completely solve obesity, but yo-yo or serious side effects have been reported, so there is no clear guarantee on safety. In addition, since obesity from the aesthetic point of view requires an additional effect on the skin in addition to lipolysis, it can be said that the application of these therapies is still inadequate to meet all necessary conditions. Therefore, there is a need to develop a new material that is equivalent to or higher than the conventional material but more safe for the human body.
본 발명은 전술한 종래 기술의 문제점을 해결하기 위한 것으로서, 피부에 적용하여 직접적으로 지방 세포 내의 지방을 분해하고 및 셀룰라이트 제거 효과를 나타낼 수 있는 지방 분해용 화장료 조성물을 제공하는 것을 목적으로 한다.The present invention is to solve the above-mentioned problems of the prior art, it is an object to provide a cosmetic composition for lipolysis that can be applied to the skin to directly decompose fat in fat cells and exhibit cellulite removal effect.
본 발명은, 레몬밤잎 추출물을 유효성분으로 하여 도포되는 영역의 지방을 분해하는 화장료 조성물을 제공하는 것을 목적으로 한다.An object of the present invention is to provide a cosmetic composition that decomposes fat in a region to be applied by using lemon balm leaf extract as an active ingredient.
본 발명의 실시예에 따르면, 레몬밤잎 추출물을 유효성분으로 하는 지방 분해용 화장료 조성물을 제공한다.According to an embodiment of the present invention, it provides a cosmetic composition for lipolysis using lemon balm leaf extract as an active ingredient.
본 발명의 다른 실시예에 따르면, 정제수, 소듐클로라이드, 레몬밤잎 추출물, 가시치엽수씨추출물, 호두(JuglansRegia) 추출물, 타이로신(Tyrosine), 블래더랙추출물(ㅍFUCUS VESICULOSUS EXTRACT), 아데노신포스페이트(Adenosine Phosphate), 다이소듐아데노신트라이포스페이트(DISODIUM ADENOSINE TRIPHOSPHATE), 메틸프로판다이올(METHYLPROPANEDIOL), 메틸실란올만누로네이트(METHYLSILANOL MANNURONATE)를 포함하는 지방 분해용 화장료 조성물을 제공한다.According to another embodiment of the present invention, purified water, sodium chloride, lemon chestnut leaf extract, spinach seed extract, walnut (Juglans Regia) extract, tyrosine (Tyrosine), bladder rack extract (FUFUUS VESICULOSUS EXTRACT), adenosine phosphate (Adenosine Phosphate) ), Disodium adenosine triphosphate (DISODIUM ADENOSINE TRIPHOSPHATE), methyl propanediol (METHYLPROPANEDIOL), methyl silanol mannuronate (METHYLSILANOL MANNURONATE) provides a cosmetic composition for fat decomposition.
본 발명의 다른 실시예에 따르면, 소듐클로라이드 0.898중량%, 레몬밤잎 추출물 0.01875중량%, 타이로신 0.00800중량%, 가시칠엽수씨추출물 0.00560중량%, 호두추출물 0.00560중량%, 블래더랙추출물 0.00240중량%, 아데노신포스페이트 0.00024중량%, 다이소듐아데노신트라이포스페이트 0.00024중량%, 메틸프로판다이올 0.04000중량%, 메틸실란올만누로네이트 0.00180중량% 및 잔량의 정제수를 포함하는 지방 분해용 화장료 조성물을 제공한다.According to another embodiment of the present invention, 0.898% by weight of sodium chloride, 0.01875% by weight of lemon balm leaf extract, 0.00800% by weight of tyrosine, 0.00560% by weight of horse chestnut extract, 0.00560% by weight of walnut extract, 0.00240% by weight of bladder extract, adenosine phosphate Provided is a cosmetic composition for decomposing fat comprising 0.00024% by weight, disodium adenosine triphosphate, 0.00024% by weight, methylpropanediol 0.04000% by weight, methylsilanol mannuronate 0.00180% by weight and the residual amount of purified water.
본 발명에 따르면, 레몬밤잎 추출물을 유효성분으로 하여 도포되는 영역의 지방을 분해하고 셀룰라이트를 제거하는 화장료 조성물을 제공할 수 있다.According to the present invention, it is possible to provide a cosmetic composition for decomposing fat and removing cellulite by applying lemon balm leaf extract as an active ingredient.
도 1 및 2는 임상 결과를 나타낸 표이다.
도 2는 본 발명의 실시예에 따른 지방 분해 조성물 투입 전 지방 세포가 분포된 조직을 나타낸 확대 사진이다.
도 3 은 본 발명의 실시예에 따른 지방 분해 조성물 투입 후 지방 세포가 80% 감소된 조직을 나타낸 확대 사진이다.
도 4 및 5는 본 발명의 실시예에 따른 지방 분해 조성물을 이용한 시술을 4주간 수행하기 전 후의 사진을 나타낸다.1 and 2 are tables showing the clinical results.
Figure 2 is an enlarged photograph showing a tissue in which fat cells are distributed before the lipolysis composition is added according to an embodiment of the present invention.
3 is an enlarged photograph showing a tissue in which fat cells are reduced by 80% after incorporation of a lipolytic composition according to an embodiment of the present invention.
4 and 5 show photographs before and after performing a procedure using a lipolysis composition according to an embodiment of the present invention for four weeks.
이하, 본 발명의 구체적인 실시예를 첨부한 도면을 참조하여 상세히 설명한다.Hereinafter, exemplary embodiments of the present invention will be described in detail with reference to the accompanying drawings.
본 발명의 실시예에 따른 레몬밤 추출물을 유효성분으로 포함하는 지방분해용 화장료 조성물은 지방 분해, 림프 순환, V라인 얼굴, 탄력있는 얼굴을 위해 화장료 조성물로 도포될 수 있다.The lipolytic cosmetic composition comprising the lemon balm extract according to the embodiment of the present invention as an active ingredient may be applied as a cosmetic composition for lipolysis, lymph circulation, V-line face, elastic face.
삭제delete
본 발명의 실시예에 따른 지방 분해 조성물은 레몬밤잎 추출물, 마로니에(Aesculus Hippocastanum) 추출물, 푸쿠스 베시쿨로수스(FucusVesiculosus) 추출물, 호두(JuglansRegia) 추출물, ADP(Disodium Adenosine Phosphate), Adenosine Triphosphate, Tyrosine을 포함하는 것이 바람직하다.Lipolytic composition according to an embodiment of the present invention is lemon balm leaf extract, horse chestnut (Aesculus Hippocastanum) extract, Fucus Veciculus (FucusVesiculosus) extract, walnut (JuglansRegia) extract, ADP (Disodium Adenosine Phosphate), Adenosine Triphosphate, Tyrosine It is preferable to include.
본 발명의 실시예에 따른 지방 분해용 화장료 조성물은 다음 성분으로 구성되는 것이 바람직하다.Fatty cosmetic composition according to an embodiment of the present invention is preferably composed of the following components.
표1은 본 발명의 일 실시예에 따른 지방 분해용 화장료 조성물의 성분 및 배합 비율을 나타낸 표이다. 숫자는 중량%를 나타낸다.Table 1 is a table showing the components and the blending ratio of the cosmetic composition for fat decomposition according to an embodiment of the present invention. The numbers represent weight percent.
레몬밤(Melissa officinalis)은 꿀풀과(Labiatae)에 속하는 식물로, 다양한 활성 플라보노이드(시나로사이드(cynaroside), 코스모신(cosmosin), 람노시트린(rhamnocitrin), 이소퀘르시트린(isoquercitrin)), 테르펜및 트리테르펜산(triterpene acids: 우르솔산(ursolic acid) 및 올레아놀산(oleanolic acid))을 함유하고 있는 것으로 알려져 있고(Herodez SS, Hadolin M, Skerget M, Knez Z Solvent extraction study of antioxidants from balm (Melissa officinalis L) leaves Food Chemistry 200;80:275-82), 정유, 카페인산 및 로즈마린산, 모노테르펜과 세스퀴테르펜, 페놀계 물질 및 탄닌 등의 활성성분 역시 레몬밤에서 분리 추출되었다. 현재까지 레몬밤 추출물의 항패혈증(Ulbricht C, Brendler T, Gruenwald J, Kligler B, Keifer D, Abrams TR, Woods J, Boon H, Kirkwood CD, Hackman DA, Basch E, Lafferty HJ; Natural Standard Research Collaboration Lemon balm (Melissa officinalis L): an evidence-based systematic review by the Natural Standard Research Collaboration J Herb Pharmacother 2005;5:71-114), 항바이러스), 항균 및 항산화 활성이 보고되어 왔다(Bolkent S, Yanardag R, Karabulut-Bulan O, Yesilyaprak B Protective role of Melissa officinalis L extract on liver of hyperlipidemic rats: a morphological and biochemical study J Ethnopharmacol 2005;99:391-8, Ali Zarei1 , Saeed Changizi Ashtiyani, Soheila Taheri, Fateme Rasekh Comparison between effects of different doses ofofficinalisatorvastatin on the activity of liver enzymes in hypercholesterolemia rats AJP 2014; 4(1) 15-23). 또한, 레몬밤잎 추출물은 Melissa officinalis leaf extract로 지중해 연안 및 중부에 자생하며 "멜리사"라고도 불리는 허브식물로 레몬과 비슷한 향이 특징이며 풍부한 로즈마린산 성분을 함유한다. 로즈마린산은 다이어트, 항산화, 항염 작용에 도움을 준다. 레몬밤잎 추출물은 폴리페놀과 타닌 성분으로 피부 보호에도 탁월한 효능을 가진다. 레몬밤 추출물은 물, 메탄올, 에탄올 및 이들 중 2종 이상의 혼합물로 이루어지는 군으로부터 선택되는 극성용매, 바람직하게는 물로 레몬밤 전초, 바람직하게는 레몬밤의 잎을 추출하고 분무건조시켜 분말화한 것이다. 본 실시예에서는 레몬밤 추출물의 피부 적용 시 지방 및 셀룰라이트 감소 효과를 이용한 것이다. Lemon balm (Melissa officinalis) is a plant belonging to the labiatae, a variety of active flavonoids (cynaroside, cosmosin, rhamnocitrin, isoquercitrin, terpene and It is known to contain triterpene acids (ursolic acid and oleanolic acid) (Herodez SS, Hadolin M, Skerget M, Knez Z Solvent extraction study of antioxidants from balm (Melissa officinalis L ) Leaves Food Chemistry 200; 80: 275-82), essential oils, caffeic and rosemary acids, monoterpenes and sesquiterpenes, phenolic substances and tannins were also extracted from lemon balm. Antiseptic of lemon balm extract to date (Ulbricht C, Brendler T, Gruenwald J, Kligler B, Keifer D, Abrams TR, Woods J, Boon H, Kirkwood CD, Hackman DA, Basch E, Lafferty HJ; Natural Standard Research Collaboration Lemon balm (Melissa officinalis L): an evidence-based systematic review by the Natural Standard Research Collaboration J Herb Pharmacother 2005; 5: 71-114), antiviral), and antimicrobial and antioxidant activities have been reported (Bolkent S, Yanardag R, Karabulut-Bulan O, Yesilyaprak B Protective role of Melissa officinalis L extract on liver of hyperlipidemic rats: a morphological and biochemical study J Ethnopharmacol 2005; 99: 391-8, Ali Zarei1, Saeed Changizi Ashtiyani, Soheila Taheri, Fateme Rasekh Comparison between effects of different doses ofofficinalisatorvastatin on the activity of liver enzymes in hypercholesterolemia rats AJP 2014; 4 (1) 15-23). The lemon balm leaf extract is a medicinal herb of Melissa officinalis leaf extract, which grows in the Mediterranean and central regions, and is also called "Melissa". It has a lemon-like scent and contains abundant rosemary acid. Rosemary acid helps with diet, antioxidants and anti-inflammatory effects. Lemon balm leaf extract is excellent in protecting skin with polyphenol and tannin. Lemon balm extract is powdered by extracting and spray drying the leaves of lemon balm starch, preferably lemon balm with a polar solvent selected from the group consisting of water, methanol, ethanol and a mixture of two or more thereof. . In this embodiment, the lemon balm extract was used to reduce fat and cellulite when applied to the skin.
가시칠엽수씨추출물(AESCULUS HIPPOCASTANUM (HORSE CHESTNUT) SEED EXTRAC)은 항부종작용, 항염증작용, 혈관 조직 벽에 대해 부종형성방지, 급약성의 감소 뿐만 아니라 피부를 자외선으로부터 지켜 기미를 예방해주며 거친 피부를 방지하는 효과가 있다.AESCULUS HIPPOCASTANUM (HORSE CHESTNUT) SEED EXTRAC is an anti-edema, anti-inflammatory, edema formation on the walls of vascular tissues, decreases sharpness, protects the skin from UV rays, prevents blemishes, It is effective to prevent.
호두추출물(JUGLANS REGIA (WALNUT) SEED EXTRACT)은 세포에서 각질형성세포에 의한 각질층의 분화를 촉진하고, 손상된 피부의 장벽기능을 회복시키며, 보습력 증가 및 유지에 뛰어난 효과가 있을 뿐만 아니라, 비만세포에서의 탈 과립저해 및 면역세포증식 효과가 뛰어나며 항염, 자극완화 효과가 있다. Walnut Extract (JUGLANS REGIA (WALNUT) SEED EXTRACT) promotes the differentiation of the stratum corneum by keratinocytes in the cell, restores the barrier function of damaged skin, and has an excellent effect on increasing and maintaining moisturizing power. Degranulation inhibitory and immune cell proliferation effect of the excellent anti-inflammatory, irritant effect.
블래더랙추출물(FUCUS VESICULOSUS EXTRACT)은 큰 갈조류 해초로부터 추출한 성분으로 다량의 미네랄, 비타민, 아미노산을 함유하고 있어 피부를 보호하고 수화하며 거칠고 건조한 피부를 촉촉하게 하는 효과가 있다. 지방을 흡수하고 노폐물 배출에 도움을 준다.FRACUS VESICULOSUS EXTRACT is an ingredient extracted from large brown seaweed and contains a large amount of minerals, vitamins and amino acids, which protects and hydrates the skin and moisturizes rough and dry skin. It absorbs fats and helps with waste products.
소듐클로라이드(SODIUM CHLORIDE)는 소듐(나트륨)과 클로라이드(염화물)의 화합물인 무기염 성분으로 화장품 및 미용제품에서 산도 조절제, 방부기능, 향미제, 점도증진제로써 사용된다.Sodium chloride (SODIUM CHLORIDE) is an inorganic salt that is a compound of sodium (sodium) and chloride (chloride). It is used as an acidity regulator, antiseptic, flavoring agent and viscosity enhancer in cosmetics and beauty products.
메틸프로판다이올(METHYLPROPANEDIOL)은 용매로 사용되는 글라이콜의 일종이다. 각종 성분들이 피부에 침투하도록 도움을 준다. 수화(Hydrating) 속성이 있으며, 피부를 부드럽고 촉촉하게 하는데 도움을 준다.Methylpropanediol (METHYLPROPANEDIOL) is a type of glycol used as a solvent. Helps ingredients penetrate the skin. Hydrating properties help to soften and moisturize the skin.
타이로신(TYROSINE)은 멜라닌의 생성을 시작하는 피부 아미노산이다. 체내 카테콜아민(Catecholamine), 갑상선 호르몬인 티록신(Thyroxine)의 전구체로, 지방대사를 촉진한다.TYROSINE is a skin amino acid that initiates the production of melanin. Catecholamine in the body, a precursor of thyroid hormone thyroxine, promotes fat metabolism.
메틸실란올만누로네이트(METHYLSILANOL MANNURONATE)은 유기 실리콘 Organic silicon(SI)인 실라놀(Silanol)과 갈조류의 알긴산에서 유래한 마누론산(Mannuronic Acid)가 결합된 물질로, 피부재생, 탄력강화, 튼살 방지 효과 및 항산화, 지방분해, 보습 효과 등이 있다.METHYLSILANOL MANNURONATE is a combination of organic silicon organic silicon (SI), silanol, and mannuronic acid derived from alginic acid of brown algae. Preventive effect, antioxidant, lipolysis, moisturizing effect.
아데노신포스페이트(ADENOSINE PHOSPHATE)는 복합성, 주름개선, 항염제, 진정제, 세포대화성분으로 진피층 내 피부 세포 활성화 산소를 전달하며 섬유아세포의 크기 증대 및 증식을 강화하여 콜라겐 합성을 촉진한다.Adenosine phosphate (ADENOSINE PHOSPHATE) is a complex, anti-wrinkle, anti-inflammatory, sedative, and cell-communicating agent that delivers skin cell activated oxygen in the dermal layer and promotes collagen synthesis by enhancing the size and proliferation of fibroblasts.
다이소듐아데노신트라이포스페이트(DISODIUM ADENOSINE TRIPHOSPHATE)는 아데노신 트리포스페이트의 디소듐염 성분이다. 피부에 컨디셔닝을 부여하는 역할로 사용된다.DISODIUM ADENOSINE TRIPHOSPHATE is a disodium salt component of adenosine triphosphate. Used to impart conditioning to the skin.
도 5 는 레몬밤 추출물을 포함하는 본 발명의 실시예에 따른 조성물이 지방 세포에 대한 작용 결과를 나타낸 전자 현미경 사진을 나타낸다. (a)는 조성물 투입전 사진이고, (b)은 조성물 투입 후 사진이다. 빨간색 동그라미가 지방 세포를 나타내고 약 80%의 지방 세포가 감소했음을 확인할 수 있다.Figure 5 shows an electron micrograph showing the result of the action on the adipocytes composition according to an embodiment of the present invention comprising a lemon balm extract. (a) is a photograph before adding the composition, (b) is a photograph after adding the composition. You can see that the red circle shows fat cells and about 80% of fat cells are reduced.
상기 조성물을 이용하여 2019년 1월부터 3월까지 100명의 피시술자를 대상으로 임상을 실시하였다. Clinical trials were performed on 100 subjects from January to March 2019 using the composition.
피시술자들은 다음 표 2와 같이 피시술자의 셀룰라이트 종류로 분류되었다.The subjects were classified into cellulite types of the subjects as shown in Table 2 below.
피시술자의 나이는 다음과 같았다. 70%의 피시술자가 15~35세였다. The age of the subject was as follows. 70% of the subjects were 15 to 35 years old.
순환계 계통 질병이 특히 중요하지만, 셀룰라이트와 관련된 증상은 아래 표 4와 같이 매우 다양했다. Although circulatory disease is particularly important, the symptoms associated with cellulite varied widely as shown in Table 4 below.
(family history of varicose veins)Varicose vein abnormalities in family history
(family history of varicose veins)
표4에서 보는 바와 같이, 65%의 피시술자가 정맥환류결핍 (deficient venous return), 44%가 가족력의 정맥류혈관이상 (family history of varicose veins), 31%가 적어도 생리 2일전에 복사 부종 (malleolar edema)을 보였다. 모든 이러한 증상들이 혈관과 관련이 매우 깊다 (vascular manifestations) 그러므로 빈약한 순환기능 (poor circulatory function)과 미용학적 셀룰라이트 문제 (esthetic cellulite problems)와 관계가 있다는 것이 통계적으로 증명이 되었다. As shown in Table 4, 65% of the subjects had a deficient venous return, 44% had a family history of varicose veins, and 31% had at least two days prior to menstrual edema (malleolar edema). ) All these symptoms are statistically proven to be related to vascular manifestations and thus to poor circulatory function and esthetic cellulite problems.
전자부주위 (peritrochanteric, 轉字部周圍)와 무릎 안쪽을 포함한 시술해당부위 전체에 일렉트로포레이션(electroporation)을 적용하였고, 다음과 같은 결과를 얻었다. 전기천공법이라는 뜻을 가진 일렉트로포레이션(electroporation)은 피부 지질에 전기 펄스를 가해 일시적으로 피부지질을 열기 때문에 본 발명의 실시예에 따른 조성물과 같은 포뮬러 흡수에 보다 효과적이다.Electroporation was applied to the entire area, including the peritrochanteric and the inside of the knee. The results were as follows. Electroporation, which means electroporation, is more effective for absorbing a formula such as a composition according to an embodiment of the present invention because electroporation temporarily opens skin lipids by applying an electric pulse to skin lipids.
임상은 매주 1회씩 피시술자의 상태에 따라 4~10주간에 걸쳐서 진행되었다. 그 후에는 격주에 1회, 총 2회를 진행하였고, 2회 실시 후에는 "유지목적"으로 한달에 1회만을 진행하였다. 1회당 시간은 최소 30분에서 최대 40분이었으며, 파워레벨은 75 ~ 90%이었다. 적용부위에 부드럽게 원을 그리듯이 마사지를 한다는 점에 주의한다. "유지목적" 시술을 제외하고 총 5~10회의 시술을 받은 피시술자는 전체의 71%였으며, "유지목적" 시술을 포함하여 11~20회를 받은 피시술자가 25%, 21회 이상을 받은 피시술자가 4%였다. Clinical trials were conducted once a week for 4 to 10 weeks, depending on the condition of the subject. After that, a biweekly session was held, and a total of two sessions were conducted. After two sessions, the program was held only once a month for "maintenance purposes." The time per run ranged from a minimum of 30 minutes to a maximum of 40 minutes with a power level of 75 to 90%. Note that you massage the area gently with a circle. 71% of the total patients received 5 ~ 10 procedures except for “maintain” procedure, 25% of those who received 11 ~ 20 times including “maintain” procedure and 25% who received more than 21 times 4%.
몸무게 감량의 변화는 다음 표 5와 같다.Changes in weight loss are shown in Table 5 below.
도 1은 전자부주위(peritrochanteric, 轉字部周圍) 지름 감소폭을 나타낸 표이다. 21%가 2cm, 46%가 3cm, 21%가 4cm 감소 효과를 나타내었다.1 is a table showing a diameter reduction range of the peritrochanteric (eric 字 部 周圍). 21% had 2cm, 46% had 3cm, and 21% had 4cm reduction.
도 2는 피시술자들의 종합 평가를 나타낸 표이다. 시술에 대한 피시술자들의 주관적인 평가가 이루어졌으며, 평가기준은 몸무게의 변화뿐만이 아니라 시술 과정에서 나타날 수 있는 증후군 (부작용)의 정도와 일상생활로의 빠른 복귀 등도 포함이 되어 있었다. 2 is a table showing the comprehensive evaluation of the subjects. Subjective evaluations were performed by the subjects. The criteria included not only changes in body weight, but also the degree of syndrome (side effects) that may occur during the procedure and a rapid return to daily life.
3%의 피시술자에게서 양쪽 넓적다리에서의 일반적인 혈관확장이 관찰되었다. 이것은 일과성 (transient, 一過性)이고 통증이 없는 것이었으며, 미주신경 (vagal, 迷走神經)에 의한 증상은 아니었다. 아랫쪽 넓적다리 부분이 흐릿하게 붉어졌다가 없어지는 현상으로, 동종요법 제품에 대한 반응 정도로 이해가 된다. In 3% of subjects, general vasodilation in both thighs was observed. It was transient and painless, and was not symptomatic of the vagal nerves. The lower thigh is reddish and then faded out, which makes sense as a response to homeopathic products.
주목 할 만한 사실은, 임상에 참가한 피시술자 중 단 한 명도 내성이 생기지 않았고 동종요법에 대한 거부 반응도 나타나지 않았다는 것이다. 피시술자들의 제품에 대한 수용(acceptance)이 매우 뛰어났으며, 가려움증, 부어오름, 알레르기 현상, 고통, 심각한 홍반 등은 전혀 없었다. Notably, none of the participants in the clinic did not develop resistance and there was no rejection of homeopathy. The acceptance of the product by the subjects was very good and there was no itching, swelling, allergy, pain or severe erythema.
도 3은 29세 여성의 시술 전(a) 후(b)의 사진이다, 일주일에 1회씩 6회 시술한 결과이다.Figure 3 is a photograph of the 29-year-old woman before the procedure (a) after (b), the results of the procedure six times a week.
도 4는 43세 여성의 시술 전(a) 후(b)의 사진이다, 일주일에 1회씩 10회 시술한 결과이다.4 is a photograph of a 43-year-old woman before (a) and after (b), the results of the
도시된 바와 같이, 지방 및 셀룰라이트의 분해로 드라마틱한 변화를 확인할 수 있다.As shown, the breakdown of fat and cellulite may reveal dramatic changes.
Claims (3)
소듐클로라이드 0.898중량%, 레몬밤잎 추출물 0.01875중량%, 타이로신 0.00800중량%, 가시칠엽수씨추출물 0.00560중량%, 호두추출물 0.00560중량%, 블래더랙추출물 0.00240중량%, 아데노신포스페이트 0.00024중량%, 다이소듐아데노신트라이포스페이트 0.00024중량%, 메틸프로판다이올 0.04000중량%, 메틸실란올만누로네이트 0.00180중량% 및 잔량의 정제수를 포함하고,
상기 조성물은 초음파기기, 고주파기기, 일렉트로포레이션, 또는 바늘없는 인젝트와 함께 피부에 적용되는 것을 특징으로 하는 지방 분해용 조성물.
In the cosmetic composition for lipolysis,
Sodium chloride 0.898%, lemon chestnut leaf extract 0.01875% by weight, tyrosine 0.00800% by weight, spinach chinensis seed extract 0.00560% by weight, walnut extract 0.00560% by weight, bladder rack extract 0.00240%, adenosine phosphate 0.00024% by weight, disodium adenosine triphosphate 0.00024% by weight, methylpropanediol 0.04000% by weight, methylsilanol mannuronate 0.00180% by weight and the balance of purified water,
The composition is a composition for lipolysis, characterized in that applied to the skin with an ultrasonic device, high frequency device, electroporation, or needle-free inject.
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190050030A KR102027827B1 (en) | 2019-04-29 | 2019-04-29 | Composition comprising lemon balm extract for lipolysis |
PCT/KR2019/017047 WO2020197041A1 (en) | 2019-03-25 | 2019-12-04 | Injectable and cosmetic compositions comprising lemon balm extract as active ingredient |
JP2019234300A JP6943941B2 (en) | 2019-03-25 | 2019-12-25 | Injectable and cosmetic compositions containing lemon balm extract as an active ingredient |
CN202010024143.1A CN111728903B (en) | 2019-03-25 | 2020-01-10 | Injection and cosmetic composition containing lemon balm extract as active ingredient |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190050030A KR102027827B1 (en) | 2019-04-29 | 2019-04-29 | Composition comprising lemon balm extract for lipolysis |
Publications (1)
Publication Number | Publication Date |
---|---|
KR102027827B1 true KR102027827B1 (en) | 2019-10-02 |
Family
ID=68422989
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020190050030A KR102027827B1 (en) | 2019-03-25 | 2019-04-29 | Composition comprising lemon balm extract for lipolysis |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102027827B1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102137136B1 (en) * | 2019-11-29 | 2020-08-13 | 주식회사 어바웃굿즈 | Composition comprising pumpkin hydrolysis extract, amorphophallus paeoniifolius hydrolysis extract, curcuma extract and cacao nibs extract |
WO2020197041A1 (en) * | 2019-03-25 | 2020-10-01 | 임재선 | Injectable and cosmetic compositions comprising lemon balm extract as active ingredient |
KR20210132347A (en) | 2020-04-27 | 2021-11-04 | 박민희 | Cosmetic composition for edema reduction or lipolysis |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004059519A (en) * | 2002-07-30 | 2004-02-26 | Noevir Co Ltd | Skin cosmetic for thin figure |
KR100998990B1 (en) | 2003-12-29 | 2010-12-09 | (주)아모레퍼시픽 | Composition for slimming |
KR20120086436A (en) * | 2011-01-26 | 2012-08-03 | 주식회사 코스메카코리아 | Cosmetic composition for slimming |
KR20130133285A (en) * | 2012-01-23 | 2013-12-06 | 레스토시, 엘엘씨 | Cosmetic |
KR101545706B1 (en) | 2013-05-10 | 2015-08-26 | 주식회사 아미팜 | Composition comprising phosphatidylcholine for lipolysis and manufacturing method thereof |
JP2018016549A (en) * | 2016-07-25 | 2018-02-01 | 一丸ファルコス株式会社 | Nutrient absorption-improving agent |
KR101865914B1 (en) | 2016-02-25 | 2018-06-12 | 오명진 | Parenteral solution for diet containing lipolysis and celluite-improoving ingredient |
KR101909869B1 (en) | 2018-04-27 | 2018-10-18 | 최정윤 | Injection liquid composition for localized lipolysis and smart mixing system for it |
-
2019
- 2019-04-29 KR KR1020190050030A patent/KR102027827B1/en active IP Right Grant
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004059519A (en) * | 2002-07-30 | 2004-02-26 | Noevir Co Ltd | Skin cosmetic for thin figure |
KR100998990B1 (en) | 2003-12-29 | 2010-12-09 | (주)아모레퍼시픽 | Composition for slimming |
KR20120086436A (en) * | 2011-01-26 | 2012-08-03 | 주식회사 코스메카코리아 | Cosmetic composition for slimming |
KR20130133285A (en) * | 2012-01-23 | 2013-12-06 | 레스토시, 엘엘씨 | Cosmetic |
KR101545706B1 (en) | 2013-05-10 | 2015-08-26 | 주식회사 아미팜 | Composition comprising phosphatidylcholine for lipolysis and manufacturing method thereof |
KR101865914B1 (en) | 2016-02-25 | 2018-06-12 | 오명진 | Parenteral solution for diet containing lipolysis and celluite-improoving ingredient |
JP2018016549A (en) * | 2016-07-25 | 2018-02-01 | 一丸ファルコス株式会社 | Nutrient absorption-improving agent |
KR101909869B1 (en) | 2018-04-27 | 2018-10-18 | 최정윤 | Injection liquid composition for localized lipolysis and smart mixing system for it |
Non-Patent Citations (1)
Title |
---|
매일경제, 레몬밤 지방분해부터 생리통 완화까지(2019.04.13.) 1부.* * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020197041A1 (en) * | 2019-03-25 | 2020-10-01 | 임재선 | Injectable and cosmetic compositions comprising lemon balm extract as active ingredient |
KR102137136B1 (en) * | 2019-11-29 | 2020-08-13 | 주식회사 어바웃굿즈 | Composition comprising pumpkin hydrolysis extract, amorphophallus paeoniifolius hydrolysis extract, curcuma extract and cacao nibs extract |
KR20210132347A (en) | 2020-04-27 | 2021-11-04 | 박민희 | Cosmetic composition for edema reduction or lipolysis |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105616283B (en) | A kind of plant essence restorative facial cream | |
CN106726965B (en) | Anti-allergy and soothing skin care product composition and preparation method thereof | |
KR102027827B1 (en) | Composition comprising lemon balm extract for lipolysis | |
CN108553389A (en) | A kind of plant moisturizing after-sun frost and preparation method thereof | |
CN108452275A (en) | It is a kind of to have effects that the composition, medicament and preparation method of relaxing tendons and activating collaterals | |
CN109528613A (en) | Moisten white cosmetic composition, the white skin lightening Essence of profit and its preparation method and application | |
CN108938759B (en) | Medicine or daily chemical product composition for treating hand-foot syndrome and preparation method and application thereof | |
US20190216871A1 (en) | Diabetic foot cream | |
KR20220168132A (en) | Composition for skin containing pine bark extract having edema relief, cellulite reduction and whitening effects, and skin cream using the same | |
CN106580838A (en) | Traditional Chinese medicine essence with effects of whitening and fading spots and preparation method of traditional Chinese medicine essence | |
KR102611063B1 (en) | Massage cream composition and method for manufacturing the same. | |
KR20090020234A (en) | Cosmetic composition containing herb medicine extracts and powders | |
CN108567862A (en) | Mite killing is releived compound borneol essential oil and preparation method thereof | |
CN106620633A (en) | Skin repairing cream for tumor patients and preparation method of skin repairing cream | |
CN108938511B (en) | Composition of natural plant extracts and application of composition in skin moisturizing and acne removing products | |
CN106890120A (en) | A kind of Chinese medicine Whitening, spot breast and preparation method thereof | |
CN106924134A (en) | A kind of Chinese medicine whitening spot-relieving cream and preparation method thereof | |
KR102036186B1 (en) | Composition comprising lemon balm extract for lipolysis | |
CN107441340B (en) | Hand and foot chap cream for relieving swelling, pain and itching and nourishing skin and preparation method thereof | |
RU2314093C2 (en) | Curative-cosmetic agent | |
KR20060093164A (en) | Anti-wrinkle cosmetic composition | |
AU2018359924A1 (en) | Composition for eliminating striae distensae | |
KR20110060200A (en) | Slimming cosmetic composition containing capsaicin | |
JP6943941B2 (en) | Injectable and cosmetic compositions containing lemon balm extract as an active ingredient | |
CN106727051A (en) | A kind of Chinese medicine anti-acne elite and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |